Zevtera: FDA Approves New Antibiotic For Pediatric Pneumonia, Staph, and Bacterial Skin Infections
After seeing the results of a randomized, controlled, double-blind, multinational, multi-center trial where 390 subjects got either Zevtera (192) or daptomycin plus optional aztreonam [the comparator…